Imraan Joosub

Department of Pharmacy, Prince Muhammed Bin Abdulaziz Hospital, Madinah Al-Monowarrah, Kingdom of Saudi Arabia

Publications
  • Research Article   
    Extemporaneous Compounding of Furosemide Oral Liquid Formulations: A Systemic Review
    Author(s): Imraan Joosub*, Mohammed Al-Anezi, Zohair Emara and Eman Youssif

    Small-scale compounding of oral liquid dosage forms lacks long-term safety and efficacy data of commercially available medicines. Medication shortages of furosemide syrup continue to burden healthcare treatment. Extemporaneous compounding of commercially available registered drugs is prohibited, except under exceptional circumstances. Compounding an alcohol-free furosemide oral liquid may be safe for pediatric patients. This study aims to alleviate a nationwide shortage of furosemide syrup via a literature review of extemporaneous compounding resources. Investigators performed a literature review and found that 8 of the 13 stability studies of furosemide oral liquids were alcohol-free with at least a 30-day shelf life, and may be suitably compounded for pediatric patients. In the absence of a commercially available furosemide syrup, this review found safe alternat.. View more»

    DOI: 10.35248/2153-2435.23.14.750

    Abstract HTML PDF